144 related articles for article (PubMed ID: 26928462)
21. Enhanced susceptibility of adriamycin-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes and tumor infiltrating lymphocytes.
Wu XX; Zeng Y; Jin XH; Kakehi Y
Oncol Rep; 2007 Aug; 18(2):353-9. PubMed ID: 17611656
[TBL] [Abstract][Full Text] [Related]
22. Purified MHC class I and peptide complexes activate naive CD8+ T cells independently of the CD28/B7 and LFA-1/ICAM-1 costimulatory interactions.
Goldstein JS; Chen T; Brunswick M; Mostowsky H; Kozlowski S
J Immunol; 1998 Apr; 160(7):3180-7. PubMed ID: 9531273
[TBL] [Abstract][Full Text] [Related]
23. Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity.
Bhat P; Leggatt G; Waterhouse N; Frazer IH
Cell Death Dis; 2017 Jun; 8(6):e2836. PubMed ID: 28569770
[TBL] [Abstract][Full Text] [Related]
24. Specific down-regulation of proliferative T cell alloresponsiveness by interference with CD2/LFA-3 and LFA-1/ICAM-1 in vitro.
Böhmig GA; Kovarik J; Holter W; Pohanka E; Zlabinger GJ
J Immunol; 1994 Apr; 152(8):3720-8. PubMed ID: 7511657
[TBL] [Abstract][Full Text] [Related]
25. Th2-like response and antitumor effect of anti-interleukin-4 mAb in mice bearing renal cell carcinoma.
Takeuchi T; Ueki T; Sasaki Y; Kajiwara T; Li B; Moriyama N; Kawabe K
Cancer Immunol Immunother; 1997 Jan; 43(6):375-81. PubMed ID: 9067410
[TBL] [Abstract][Full Text] [Related]
26. Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8(+) T cells.
Schüler T; Kammertoens T; Preiss S; Debs P; Noben-Trauth N; Blankenstein T
J Exp Med; 2001 Dec; 194(12):1767-75. PubMed ID: 11748278
[TBL] [Abstract][Full Text] [Related]
27. Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo.
Scheffer SR; Nave H; Korangy F; Schlote K; Pabst R; Jaffee EM; Manns MP; Greten TF
Int J Cancer; 2003 Jan; 103(2):205-11. PubMed ID: 12455034
[TBL] [Abstract][Full Text] [Related]
28. Treatment of established tumor is associated with ICAM-1 upregulation and reversed by CD8 depletion in a tumor necrosis factor-alpha gene transfected mouse mammary tumor.
Matory YL; Dorfman DM; Wu L; Chen M; Goedegebuure P; Eberlein TJ
Pathobiology; 1999; 67(4):186-95. PubMed ID: 10738180
[TBL] [Abstract][Full Text] [Related]
29. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model.
Morales-Kastresana A; Sanmamed MF; Rodriguez I; Palazon A; Martinez-Forero I; Labiano S; Hervas-Stubbs S; Sangro B; Ochoa C; Rouzaut A; Azpilikueta A; Bolaños E; Jure-Kunkel M; Gütgemann I; Melero I
Clin Cancer Res; 2013 Nov; 19(22):6151-62. PubMed ID: 24030703
[TBL] [Abstract][Full Text] [Related]
30. Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine.
Zhou X; Jun DY; Thomas AM; Huang X; Huang LQ; Mautner J; Mo W; Robbins PF; Pardoll DM; Jaffee EM
Cancer Res; 2005 Feb; 65(3):1079-88. PubMed ID: 15705910
[TBL] [Abstract][Full Text] [Related]
31. T Cell Migration from Inflamed Skin to Draining Lymph Nodes Requires Intralymphatic Crawling Supported by ICAM-1/LFA-1 Interactions.
Teijeira A; Hunter MC; Russo E; Proulx ST; Frei T; Debes GF; Coles M; Melero I; Detmar M; Rouzaut A; Halin C
Cell Rep; 2017 Jan; 18(4):857-865. PubMed ID: 28122237
[TBL] [Abstract][Full Text] [Related]
32. Lysis of human keratinocytes by allogeneic HLA class I-specific cytotoxic T cells. Keratinocyte ICAM-1 (CD54) and T cell LFA-1 (CD11a/CD18) mediate enhanced lysis of IFN-gamma-treated keratinocytes.
Symington FW; Santos EB
J Immunol; 1991 Apr; 146(7):2169-75. PubMed ID: 1672345
[TBL] [Abstract][Full Text] [Related]
33. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules.
Vorderstrasse BA; Kerkvliet NI
Toxicol Appl Pharmacol; 2001 Mar; 171(2):117-25. PubMed ID: 11222087
[TBL] [Abstract][Full Text] [Related]
34. Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicity.
Dohlsten M; Hedlund G; Lando PA; Trowsdale J; Altmann D; Patarroyo M; Fischer H; Kalland T
Eur J Immunol; 1991 Jan; 21(1):131-5. PubMed ID: 1671356
[TBL] [Abstract][Full Text] [Related]
35. Signaling pathways activated by leukocyte function-associated Ag-1-dependent costimulation.
Ni HT; Deeths MJ; Li W; Mueller DL; Mescher MF
J Immunol; 1999 May; 162(9):5183-9. PubMed ID: 10227991
[TBL] [Abstract][Full Text] [Related]
36. Activation of tumor-specific CD8+ T Cells after intratumoral Ad5-TRAIL/CpG oligodeoxynucleotide combination therapy.
VanOosten RL; Griffith TS
Cancer Res; 2007 Dec; 67(24):11980-90. PubMed ID: 18089829
[TBL] [Abstract][Full Text] [Related]
37. Clonal heterogeneity in LFA-3 and ICAM-1 requirement for lysis by alloreactive T lymphocytes.
Galocha B; López D; López de Castro JA
J Immunol; 1993 Mar; 150(5):1653-62. PubMed ID: 7679690
[TBL] [Abstract][Full Text] [Related]
38. LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production.
Salomon B; Bluestone JA
J Immunol; 1998 Nov; 161(10):5138-42. PubMed ID: 9820482
[TBL] [Abstract][Full Text] [Related]
39. Trafficking of 'immune' CD4(+)/CD8(+)T-lymphocytes into the RENCA tumour microcirculation in vivo in mice.
Ali SA; Rees RC; Anderson DQ; Reed MW; Goepel JR; Brown NJ
Br J Cancer; 2000 Oct; 83(8):1061-8. PubMed ID: 10993655
[TBL] [Abstract][Full Text] [Related]
40. Generation of IL-2-dependent cytolytic T lymphocytes (CTLs) with altered TCR responses derived from antigen-dependent CTL clones.
Gullo CA; Esser MT; Fuller CL; Lam Braciale V
J Immunol; 1999 Jun; 162(11):6466-72. PubMed ID: 10352261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
